Legault Pierre has filed 19 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 24000 shares of Syndax Pharmaceuticals Inc ($SNDX) on February 04, 2026.
Activity breakdown: 0 open-market purchases and 3 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | A | Common Stock | 24000 | $0.00 | 114,000.0000 | 86,914,838 | 26.67% | 0.03% |
| Feb. 5, 2025 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | A | Common Stock | 25000 | $0.00 | 90,000.0000 | 0 | 38.46% | 0.00% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Not found | A | Ordinary Shares | 12500 | $0.00 | 46,000.0000 | 58,207,593 | 37.31% | 0.02% |
| Jan. 2, 2025 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 58,207,593 | 9999.99% | 0.04% |
| Feb. 7, 2024 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | A | Common Stock | 17000 | $0.00 | 65,000.0000 | 0 | 35.42% | 0.00% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Director | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 35,592,362 | 9999.99% | 0.07% |
| Jan. 2, 2024 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Director | A | Ordinary Shares | 12000 | $0.00 | 33,500.0000 | 35,592,362 | 55.81% | 0.03% |
| Feb. 2, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | A | Common Stock | 16000 | $0.00 | 48,000.0000 | 0 | 50.00% | 0.00% |
| Jan. 12, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | S | Common Stock | 24000 | $26.74 | 32,000.0000 | 0 | 42.86% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Common Stock | 10000 | $13.58 | 42,000.0000 | 0 | 31.25% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | S | Common Stock | 10000 | $27.00 | 32,000.0000 | 0 | 23.81% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Common Stock | 5000 | $13.58 | 37,000.0000 | 0 | 15.63% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | S | Common Stock | 5000 | $27.00 | 32,000.0000 | 0 | 13.51% | 0.00% |
| Jan. 12, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Common Stock | 24000 | $9.47 | 56,000.0000 | 0 | 75.00% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Stock Options (Right to buy) | 10000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 13, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Stock Options (Right to buy) | 5000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 12, 2023 | Syndax Pharmaceuticals Inc | $SNDX | Legault Pierre | Not found | M | Stock Options (Right to buy) | 24000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Director | A | Stock Option (right to buy) | 23000 | $0.00 | 23,000.0000 | 29,660,659 | 9999.99% | 0.08% |
| Jan. 3, 2023 | BICYCLE THERAPEUTICS PLC | $BCYC | Legault Pierre | Director | A | Ordinary Shares | 11500 | $0.00 | 21,500.0000 | 29,660,659 | 115.00% | 0.04% |